{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-26-030505","form_type":"8-K","ticker":"AMIX","cik":"0001617867","company_name":"Autonomix Medical, Inc.","filed_at":"2026-09-16T12:35:57+00:00","discovered_at":"2026-09-16T12:40:01.125790+00:00","generated_at":"2026-09-16T12:40:09.353495+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"positive","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"Autonomix Medical appoints former Medtronic Chief Regulatory Counsel Sandra Kalter to board","bullets":["Board expanded from five to six members; Kalter appointed independent director effective Sept 14, 2026.","Kalter spent 20 years at Medtronic, including VP and Chief Regulatory Counsel; oversaw due diligence for 27+ acquisitions.","Her Medtronic work covered Symplicity Spyral renal denervation, Evolut TAVR, Micra TPS, and PulseSelect PFA systems.","She receives standard non-employee director compensation; no committee assignments or disclosed conflicts reported."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-26-030505","json":"https://secwatch.observer/filing/0001437749-26-030505.json","markdown":"https://secwatch.observer/filing/0001437749-26-030505.md","text":"https://secwatch.observer/filing/0001437749-26-030505.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1617867/000143774926030505/0001437749-26-030505-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1617867/000143774926030505/amix20260914_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-09-16T12:40:09.353495+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"18981f8f2e","claim":"Sandra Kalter was appointed as Independent Director at Autonomix Medical, Inc..","evidence_excerpt":"On September 14, 2026, Autonomix Medical, Inc. (the “Company”) Board of Directors (the “Board”) increased the size of the Board from five to six members and appointed Sandra Kalter as an independent member of the Company’s Board, effective immediately.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1617867/000143774926030505/0001437749-26-030505-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Independent Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}